Odyssey Therapeutics revenue was $2.98M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ODTX annual revenue was $3.0M, with -33.5% growth year-over-year.
ODTX past revenue growth
How has ODTX's revenue growth performed historically?
Odyssey Therapeutics (NASDAQ: ODTX) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Odyssey Therapeutics's revenue was N/A.
What was Odyssey Therapeutics's revenue in 2025?
Odyssey Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $2.98 million, a 33.45% decrease year over year.
How much does Odyssey Therapeutics make in a day?
Based on Odyssey Therapeutics annual revenue for the past one years, ODTX makes an average of $8,153.42 per day.
What was Odyssey Therapeutics's annual revenue growth in the past year?
As of Q2 2026, Odyssey Therapeutics's revenue has grown -33.45% year over year. This is 267.14 percentage points lower than the US Biotechnology industry revenue growth rate of 233.69%. Odyssey Therapeutics's revenue in the past year totaled $2.98 million.
How much does Odyssey Therapeutics make in a year?
Odyssey Therapeutics's revenue by year for the past one years is:
Odyssey Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $2.98 million, a 33.45% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.